ALC alcidion group limited

Ann: Alcidion FY20 Half Year Report and Appendix 4D, page-2

  1. 105 Posts.
    lightbulb Created with Sketch. 81
    Hi everyone,
    This morning we released Alcidion’s Half Year Report for H1 FY2020, showing a period of investment for growth and contract wins amidst a rapidly rising digital healthcare market.

    During H1 we signed several important contracts including Healthscope, our first contract with a private provider for data and analytics, Dartford and Gravesham NHS Foundation Trust for Better’s OPENeP platform and our first NHS Global Digital Exemplar Taunton and Somerset NHS Foundation Trust for Patientrack. We also launched Miya MEMRe in Australia, the first locally developed fully mobile EMR.

    Our sales pipeline remains strong, with $15.4m sold revenue contracted to be recognised in FY2020 and $37.2m out to FY2025. In January 2020 we signed two further contracts with Calvary Health Care and eHealth NSW, adding a further $1m to be recognised in FY2020.

    Alcidion’s H1 FY2020 revenue reached $8.2 million, up 12.3% on H1 FY2019. As a result of scale-up investments in sales, marketing and product development, Alcidion delivered an overall net loss of $1.8 million in H1.

    Read Alcidion’s full H1 FY2020 results and cover note here
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
10.5¢
Change
0.000(0.00%)
Mkt cap ! $141.0M
Open High Low Value Volume
11.0¢ 11.0¢ 10.5¢ $23.16K 216.0K

Buyers (Bids)

No. Vol. Price($)
4 96856 10.5¢
 

Sellers (Offers)

Price($) Vol. No.
11.0¢ 3002979 32
View Market Depth
Last trade - 16.10pm 10/07/2025 (20 minute delay) ?
ALC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.